
Cybin
Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms.
Enterprise value
$60m
Share price
$8.39 CYBN
Recent deals
Authorizing premium user...
Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms.